Baseline characteristics and treatment information.

a: Values are expressed in median (range) or ratio for numerical values and categorical values respectively.
b: One subject had antibodies to hepatitis C virus;
c: indicates the proportion of enrolled patients with the described characteristic;
d: median (range) adherence score, on a scale of poor (1) to excellent (4), at each time point. TDF/FTC-tenofovir/emitricitabine; LPV/RTV-lopinavir/ritonavir.